These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25089505)

  • 21. A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery.
    Gao Y; Yang C; Liu X; Ma R; Kong D; Shi L
    Macromol Biosci; 2012 Feb; 12(2):251-9. PubMed ID: 22076739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
    Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
    J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. pH-sensitive poly(glutamic acid) grafted mesoporous silica nanoparticles for drug delivery.
    Zheng J; Tian X; Sun Y; Lu D; Yang W
    Int J Pharm; 2013 Jun; 450(1-2):296-303. PubMed ID: 23598077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles.
    Mussi SV; Silva RC; Oliveira MC; Lucci CM; Azevedo RB; Ferreira LA
    Eur J Pharm Sci; 2013 Jan; 48(1-2):282-90. PubMed ID: 23178339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional liquid crystal nanoparticles for intracellular fluorescent imaging and drug delivery.
    Spillmann CM; Naciri J; Algar WR; Medintz IL; Delehanty JB
    ACS Nano; 2014 Jul; 8(7):6986-97. PubMed ID: 24979226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dextran-based doxorubicin nanocarriers with improved tumor penetration.
    Sagnella SM; Duong H; MacMillan A; Boyer C; Whan R; McCarroll JA; Davis TP; Kavallaris M
    Biomacromolecules; 2014 Jan; 15(1):262-75. PubMed ID: 24313925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Oct; 30(29):5757-66. PubMed ID: 19643472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperbranched-hyperbranched polymeric nanoassembly to mediate controllable co-delivery of siRNA and drug for synergistic tumor therapy.
    Jia HZ; Zhang W; Zhu JY; Yang B; Chen S; Chen G; Zhao YF; Feng J; Zhang XZ
    J Control Release; 2015 Oct; 216():9-17. PubMed ID: 26272764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new system for targeted delivery of doxorubicin into tumor cells.
    Yabbarov NG; Posypanova GA; Vorontsov EA; Obydenny SI; Severin ES
    J Control Release; 2013 Jun; 168(2):135-41. PubMed ID: 23517785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.
    Talelli M; Iman M; Varkouhi AK; Rijcken CJ; Schiffelers RM; Etrych T; Ulbrich K; van Nostrum CF; Lammers T; Storm G; Hennink WE
    Biomaterials; 2010 Oct; 31(30):7797-804. PubMed ID: 20673684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Octreotide-mediated tumor cell uptake and intracellular pH-responsive drug delivery of the self-assembly supramolecular nanocarrier.
    Niu J; Huang A; Xiao Y; Su Z; Li H; Ping Q; Bao X; Li S; Chen Y; Sun M
    J Drug Target; 2013 May; 21(5):415-26. PubMed ID: 23597028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.
    Zhang C; Pan D; Luo K; She W; Guo C; Yang Y; Gu Z
    Adv Healthc Mater; 2014 Aug; 3(8):1299-308. PubMed ID: 24706635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photo-cross-linked and pH-sensitive biodegradable micelles for doxorubicin delivery.
    Chen J; Ouyang J; Kong J; Zhong W; Xing MM
    ACS Appl Mater Interfaces; 2013 Apr; 5(8):3108-17. PubMed ID: 23530535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of serum resistant micelles based on heparosan for targeted cancer therapy.
    Chen JX; Zhang M; Liu W; Lu GZ; Chen JH
    Carbohydr Polym; 2014 Sep; 110():135-41. PubMed ID: 24906739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH sensitive doxorubicin-loaded nanoparticle based on Radix pseudostellariae protein-polysaccharide conjugate and its improvement on HepG2 cellular uptake of doxorubicin.
    Cai X; Yang Q; Weng Q; Wang S
    Food Chem Toxicol; 2020 Feb; 136():111099. PubMed ID: 31883988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of cross-linked carboxyl poly(glycerol methacrylate) and its application for the controlled release of doxorubicin.
    Gu W; Ma Y; Zhu C; Chen B; Ma J; Gao H
    Eur J Pharm Sci; 2012 Oct; 47(3):556-63. PubMed ID: 22884627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.
    Wang T; Li M; Gao H; Wu Y
    J Colloid Interface Sci; 2011 Jan; 353(1):107-15. PubMed ID: 20947092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor-preferential sustained drug release enhances antitumor activity of block copolymer micelles.
    Ponta A; Bae Y
    J Drug Target; 2014 Aug; 22(7):619-28. PubMed ID: 24766185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced doxorubicin delivery and cytotoxicity in multidrug resistant cancer cells using multifunctional magnetic nanoparticles.
    Pilapong C; Keereeta Y; Munkhetkorn S; Thongtem S; Thongtem T
    Colloids Surf B Biointerfaces; 2014 Jan; 113():249-53. PubMed ID: 24103503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.